Aktualnie znajdujesz się na:

Janssen - a pharmaceutical company of Johnson & Johnson - has signed a cooperation agreement with WHIH

On Friday, 18.02, at the headquarters of the Medical Research Agency, Radosław Sierpinski, MD, PhD President of ABM, together with Tomasz Skrzypczak, Managing Director of Janssen in Poland, signed a Cooperation Agreement within the WHIH.

- I am extremely pleased that Janssen Polska has joined the Warsaw Health Innovation Hub today, thanks to which our company will be able to engage even more in the development of top quality innovations in the healthcare sector in Poland. I sincerely hope that soon we will be able to talk about the first joint innovative projects and initiatives, created with a view to thousands of patients waiting for a chance to live free from disease - said Managing Director of Janssen Poland, Tomasz Skrzypczak.

Given the large resources and, above all, the strong commitment of Janssen, we hope that their proposed innovative solutions to improve access to treatment will soon see the light of day. - commented MRA President Radosław Sierpiński, MD.PhD

Opcje strony

go up